Filter Results:
(1,036)
Show Results For
- All HBS Web (1,036)
- Faculty Publications (558)
Show Results For
- All HBS Web (1,036)
- Faculty Publications (558)
- September 2008 (Revised October 2008)
- Background Note
Copyright Law in the U.S. and EU
By: Robert C. Pozen and Elizabeth Leonard
This note reviews the basic rules for copyright protection in both the U.S. and the EU. It outlines the works and rights protected, the fair use and first-sale limitations on copyright, as well as the application of these rules to software, video, recordings, and... View Details
Keywords: Governing Rules, Regulations, and Reforms; Copyright; Laws and Statutes; European Union; United States
Pozen, Robert C., and Elizabeth Leonard. "Copyright Law in the U.S. and EU." Harvard Business School Background Note 309-052, September 2008. (Revised October 2008.)
- 05 Jun 2007
- Working Paper Summaries
Leading and Creating Collaboration in Decentralized Organizations
- Fall 2018
- Article
What Problems Will You Solve with Blockchain?: Before Jumping on the Bandwagon, Companies Need to Carefully Consider how Ledger Technologies Fit into their Overall Strategy
By: Teppo Felin and Karim R. Lakhani
Distributed ledger technologies — collectively known as blockchain — have burst onto the business scene, accompanied by a significant amount of hype.They are widely expected to disrupt existing industries and lead to the creation of new types of companies. Some of the... View Details
Felin, Teppo, and Karim R. Lakhani. "What Problems Will You Solve with Blockchain? Before Jumping on the Bandwagon, Companies Need to Carefully Consider how Ledger Technologies Fit into their Overall Strategy." Reprint 60115. MIT Sloan Management Review 60, no. 1 (Fall 2018).
Using the Crowd as an Innovation Partner
From Apple to Merck to Wikipedia, more and more organizations are turning to crowds for help in solving their most vexing innovation and research questions, but managers remain understandably cautious. It seems risky and even unnatural to push problems out to vast... View Details
- 13 Nov 2006
- Research & Ideas
Science Business: What Happened to Biotech?
independently; and you have to have well defined intellectual property rights. It is hard to sell stuff where the rights are not well defined. There are all sorts of hazards. These conditions are pretty well... View Details
- 2019
- Working Paper
The Consequences of Invention Secrecy: Evidence from the USPTO Patent Secrecy Program in World War II
By: Daniel P. Gross
This paper studies the effects of the USPTO's patent secrecy program in World War II, under which over 11,000 U.S. patent applications were issued secrecy orders that halted examination and prohibited inventors from disclosing their inventions or filing in foreign... View Details
Keywords: Invention Secrecy; Invention Disclosure; Trade Secrecy; Secrecy Orders; Cummulative Innovation; Wold War 2; Patents; National Security; History; Innovation and Invention; Outcome or Result; Intellectual Property; Policy; Commercialization; United States
Gross, Daniel P. "The Consequences of Invention Secrecy: Evidence from the USPTO Patent Secrecy Program in World War II." Harvard Business School Working Paper, No. 19-090, May 2019. (Revised May 2019. NBER Working Paper Series, No. 25545, May 2019)
- 24 Jul 2013
- Op-Ed
Detroit Files for Bankruptcy: HBS Faculty Weigh In
the income taxes paid by residents with good jobs, from the tolls paid by drivers, from property and sales taxes. Without revenue, costs can't be covered. Can cities with high liabilities expect to be bailed out and propped up without... View Details
Winning in Emerging Markets: A Roadmap for Strategy and Execution
Most books thus far on emerging markets are either investing-oriented, or country - or market-specific, or descriptive. No book has definitively targeted the corporate strategists who need a practical framework and assessment tools for analyzing emerging markets,... View Details
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- 2013
- Book
Business and the Environment: Critical Perspectives in Business and Management
By: Susse Georg and Andrew J. Hoffman
Over the past four decades, the concept of corporate environmentalism has passed through multiple iterations. Prompted by landmark environmental events such the publication of Rachel Carson’s Silent Spring (1962), the Santa Barbara oil spill, the Cuyahoga River fire,... View Details
Georg, Susse, and Andrew J. Hoffman, eds. Business and the Environment: Critical Perspectives in Business and Management. 4 vols. Routledge, 2013.
- April–May 2021
- Article
Labor Mobility and Antitakeover Provisions
By: Aiyesha Dey and Joshua White
How do firms protect their human capital? We test whether firms facing an increased threat of being acquired strengthen their antitakeover provisions (ATPs) in order to bond with their employees. We use the adoption of the Inevitable Disclosure Doctrine (IDD) by U.S.... View Details
Keywords: Labor Mobility; Antitakeover Provisions; Trade Secrets; Implicit Contracting; Employee Bonding; Corporate Governance; Acquisition; Human Capital; Strategy; Innovation and Invention; Intellectual Property; Safety
Dey, Aiyesha, and Joshua White. "Labor Mobility and Antitakeover Provisions." Art. 101388. Journal of Accounting & Economics 71, nos. 2-3 (April–May 2021).
- Research Summary
Great Negotiator Study Initiative
What can be legitimately be learned from closely studying great negotiators at work? Since 2000, the Program on Negotiation (PON)—an active inter-university consortium mainly comprised of numerous faculty from across... View Details
- October 2007 (Revised March 2009)
- Background Note
Structuring Real Estate Deals: An Investor's Perspective
By: Arthur I Segel
Addresses the following questions: What are the portfolio-level implications? What are the asset-level characteristics? How do I invest? With whom do I invest? What do I get for my investment? What protections do I have? When and how do I get out? View Details
Segel, Arthur I. "Structuring Real Estate Deals: An Investor's Perspective." Harvard Business School Background Note 208-066, October 2007. (Revised March 2009.)
- 13 Jan 2012
- Working Paper Summaries
Intermediaries for the IP Market
Keywords: by Andrei Hagiu & David Yoffie
- August 2008 (Revised May 2009)
- Background Note
International Enforcement of U.S. Patents
By: Robert C. Pozen and Jordan Hirsch
A company that owns a U.S. patent can enforce its patent protections in three ways: by filing a lawsuit in U.S. federal district court, by bringing action in the International Trade Commission, or through the World Trade Organization. This note discusses the pros and... View Details
Pozen, Robert C., and Jordan Hirsch. "International Enforcement of U.S. Patents." Harvard Business School Background Note 309-022, August 2008. (Revised May 2009.)
- 20 May 2014
- First Look
First Look: May 20
governance, human capital, and informational frictions help account for the variation in management. Publisher's link: http://www.nber.org/papers/w20102 August 2013 Review of Economics and Statistics Does Planning Regulation Protect... View Details
Keywords: Sean Silverthorne
- December 2005 (Revised February 2019)
- Case
Brighter Smiles for the Masses--Colgate vs. P&G
By: Felix Oberholzer-Gee, Dennis Yao and Filipa Azevedo Jorge
In 2000, Procter & Gamble Co. introduced Crest Whitestrips, a new, revolutionary product that allowed consumers to whiten their teeth at home. With Whitestrips, P&G created an entire new category in oral care, worth $460 million in 2002. Whitestrips sent P&G's main... View Details
Keywords: Competitive Advantage; Competitive Strategy; Advertising; Product Launch; Patents; Price; Performance Effectiveness; Consumer Products Industry
Oberholzer-Gee, Felix, Dennis Yao, and Filipa Azevedo Jorge. "Brighter Smiles for the Masses--Colgate vs. P&G." Harvard Business School Case 706-435, December 2005. (Revised February 2019.)
- 15 Oct 2009
- Working Paper Summaries
Mixed Source
- 01 Dec 2015
- HBS Seminar
Nicola Lacetera, University of Toronto
Dennis A. Yao
Dennis Yao is the Lawrence E. Fouraker Professor of Business Administration and Chair of the Doctoral Programs at Harvard Business School. He joined the faculty in 2004 after having been at the Wharton School, University of Pennsylvania. From 1991-1994 he served as... View Details